Cargando…

Small breast epithelial mucin as a useful prognostic marker for breast cancer patients

This study aimed to evaluate the clinical utility of small breast epithelial mucin (SBEM) as a prognostic biomarker in an independent patient cohort. The paraffin-embedded tissues and clinicopathological data of 105 patients with breast cancer were collected, and the expression of SBEM in breast can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Hui, Yang, Lin, Wang, Bingsheng, Sang, Yinzhou, Liu, Xueliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668108/ https://www.ncbi.nlm.nih.gov/pubmed/38027223 http://dx.doi.org/10.1515/biol-2022-0784

Ejemplares similares

miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM
por: Hao, Hui, et al.
Publicado: (2023)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers
por: Skliris, G P, et al.
Publicado: (2008)

Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients
por: Liu, Liang, et al.
Publicado: (2013)

Construction of a Prognostic Nomogram Model for Patients with Mucinous Breast Cancer
por: Zhu, Xulong, et al.
Publicado: (2022)

Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer
por: Borella, Fulvio, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognostic Significance of the CENP Family in Breast Cancer
por: Liu, Xueliang, et al.
Publicado: (2022)

Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation.
por: O'Sullivan, C., et al.
Publicado: (1990)

An assessment of prognostic immunity markers in breast cancer
por: Yang, Benlong, et al.
Publicado: (2018)

Giant Mucinous Carcinoma of the Breast
por: Alothman, Sara, et al.
Publicado: (2018)

Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)

RECK is not an independent prognostic marker for breast cancer
por: Gomes, Luciana R., et al.
Publicado: (2015)

Clinicopathological and genomic features of breast mucinous carcinoma
por: Lu, Kebin, et al.
Publicado: (2020)

Expression of the prognostic marker IL‐8 correlates with the immune signature and epithelial‐mesenchymal transition in breast cancer
por: Liao, Huifeng, et al.
Publicado: (2023)

MicroRNA and histopathological characterization of pure mucinous breast carcinoma
por: Zhou, Feng, et al.
Publicado: (2013)

O-linked mucin-type glycosylation in breast cancer
por: Burchell, Joy M., et al.
Publicado: (2018)

Use of mucin like cancer associated antigen (MCA) in the management of breast cancer.
por: Laurence, V., et al.
Publicado: (1991)

Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study
por: Wang, Song, et al.
Publicado: (2021)

Mucinous carcinoma in a male breast
por: Aggarwal, Roopak, et al.
Publicado: (2011)

Mucinous carcinoma occurring in the male breast
por: ISHIDA, MITSUAKI, et al.
Publicado: (2014)

Multifocal invasive mucinous carcinoma of the breast
por: Ferguson, Melissa J.
Publicado: (2020)

The Prognostic Significance of Small Size in Breast Cancer
por: Kreyberg, L., et al.
Publicado: (1953)

Survivin expression as a prognostic marker for breast cancer
por: Quidute, Patricia, et al.
Publicado: (2023)

Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
por: Liu, Guohong, et al.
Publicado: (2023)

Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers: A Meta-Analysis
por: Xu, Feng, et al.
Publicado: (2015)

CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast
por: García-Labastida, Laura, et al.
Publicado: (2014)

Foxo3a Expression Is a Prognostic Marker in Breast Cancer
por: Jiang, Ying, et al.
Publicado: (2013)

Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast
por: Feng, Xiaolong, et al.
Publicado: (2017)

Mucinous carcinoma in an octogenarian: Treatment and management of breast cancer in the elderly
por: Risner, Victoria, et al.
Publicado: (2021)

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
por: Zhang, Lianmei, et al.
Publicado: (2023)

Cancer Stem Cell-Related Gene Periostin: A Novel Prognostic Marker for Breast Cancer
por: Xu, Dongyang, et al.
Publicado: (2012)

Mucinous carcinoma of breast: Cytodiagnosis of a case
por: Sharma, Sangeeta, et al.
Publicado: (2011)

Primary Breast Mucinous Cystadenocarcinoma and Review of Literature
por: Moatasim, Ambreen, et al.
Publicado: (2022)

Primary breast mucinous cystadenocarcinoma—histopathological analysis
por: Budzik, Michał Piotr
Publicado: (2023)

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
por: Yao, Minya, et al.
Publicado: (2014)

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
por: Taneja, Pankaj, et al.
Publicado: (2010)

Nuclear osteopontin-c is a prognostic breast cancer marker
por: Zduniak, K, et al.
Publicado: (2015)

Identification of endothelial selectin as a potential prognostic marker in breast cancer
por: Zhang, Wei, et al.
Publicado: (2018)

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
por: Bai, Jin, et al.
Publicado: (2013)

Long non-coding RNAs as prognostic markers in human breast cancer
por: Liu, Hairong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ta5shl4q4jrovm1gieg928f7fd